New CEO for Israel's BioLineRx

Article

August 12, 2016

Tel Aviv, Israel-based BioLineRx Ltd. announced that Philip A. Serlin has been named Chief Executive Officer, effective October 10, 2016.   Mr. Serlin joined the company in 2009 as Chief Financial and Operating Officer. He succeeds Kinneret Savitsky, Ph.D., who has served as CEO since 2010.  Dr. Savitsky will serve as scientific advisor to the Company through the end of March 2017.

Recent Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Matthew Yelovich, Cleary Gottlieb, Theranos Case
Related Content
Stock.adobe.com

DeepL Announces HIPPA-Compliant AI

Mike Hollan
May 15th 2025
Article

The protection and privacy of healthcare data is a massive hurdle for the new technology to overcome.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Revenue Optimization: The Money Matters—That Matter Most

Revenue Optimization: The Money Matters—That Matter Most

Jesse Mendelsohn
May 9th 2025
Article

Navigating technology and regulatory shifts in pharma revenue management.

Stock.adobe.com

Blue Cross Blue Shield of Massachusetts Adds Virtual-First Primary Care Option

Mike Hollan
May 9th 2025
Article

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

Stock.adobe.com

FDA Announces ‘Aggressive’ AI Implementation Timeline

Mike Hollan
May 8th 2025
Article

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

Lunit

Lunit’s AI Technology to Power German Radiology Network

Mike Hollan
May 8th 2025
Article

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.